MarketInOut Stock Screener Log In | Sign Up
 

Crinetics Pharmaceuticals Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 05/22/2026
Crinetics Pharmaceuticals Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization3,864.91 mln
Float95.58 mln
Earnings Date08/11/2026

Piotroski F-Score

3 / 9
Below average

Beneish M-Score

17.09
Highly suspicious

1-Year Forecast

83.14
Transformational upside

Relative Strength

33 / 100
Underperforming

Debt / Equity

0.04
Debt-free

ROE

-43.01
Deeply negative

Business Description

Crinetics Pharmaceuticals is a San Diego-based drug development company working to bring new oral treatments to patients with rare hormonal disorders and related tumors. Its most advanced program is Paltusotine, a pill being tested in late-stage clinical trials for conditions such as acromegaly and hormone-secreting tumors, with commercialization rights in Japan licensed to Sanwa Kagaku Kenkyusho. The company's broader pipeline targets a range of hormonal diseases ? including Cushing's disease, Graves' disease, polycystic kidney disease, and obesity ? through several additional drug candidates at various stages of development.

Key Fundamentals

EPS-5.14
ROE-43.01
RPS0.18
ROIC-498
ROA-38.94
EBITDA, mln-542
EV / EBITDA-5.00
EV / EBIT-4.96
Revenue, mln18.07
EV / Revenue150

Financial Strength

Altman Z-Score18.02
Piotroski F-Score 3 / 9
Beneish M-Score17.09
1-Year Target Price83.14
Short Ratio12.96
Short % of Float15.74

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 0.08% 37 / 100   
1 Month -4.44% 24 / 100   
2 Months -13.82% 19 / 100   
6 Months -14.22% 24 / 100   
1 Year 22.87% 64 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us